[ad_1]
The World Health Organization (WHO) today announced that trials of two new drugs were proving to be very effective in treating Ebola in the Congo.
Scientists are on the verge of finding an effective treatment against the Ebola outbreak after drugs in a clinical trial have dramatically improved patient survival in the Democratic Republic of Congo (DRC), health authorities said US.
The study, which began in November in the Democratic Republic of Congo, will stop at this stage and all future patients will receive treatment, which has yielded positive results, according to the US Institutes of Health.
Anthony Fuchi, director of the National Institute of Allergy and Infectious Diseases, told AFP that "Regen-UP3" and "MAP114" were "the only drugs to date to have demonstrated, through from a scientific study, a significant reduction in the death rate of people infected with the Ebola virus. "
He explained that the experiment was to include 725 people but had been stopped by an independent board while the number of participants was 681 people because at this stage, both drugs had achieved a high success rate. Up to now, 499 people have badyzed data on 681. In this group, the mortality rate has fallen to 29% with Regen-UP3 and the MAP 114 has helped reduce the mortality rate to 34%, according to Fuchi, compared to a previous rate of 60-67. % Of the total number of untreated patients. These drugs block the ability of this deadly virus to grow and infect healthy cells.
The latest data badysis, which also includes untreated patients, will take place in late September or early October, after which the full results will be published, Fuchi said. The disease has killed more than 1,800 people since its epidemic in the DRC in August 2018.
[ad_2]
Source link
